Data / Drug companies / L Perrigo Company
L Perrigo Company: 15 products in the FDA NDC directory, labeler code 50941
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
L Perrigo Company (labeler code 50941) lists 15 products in the FDA National Drug Code Directory. By type: 15 drugs for further processing. Its main marketing category is drugs for further processing. The newest product started marketing on September 2, 2025.
The request: Watch L Perrigo Company (FDA labeler code 50941): each new product listing and each discontinued product. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Labeler code
- 50941
- Products in commercial distribution
- 15
- Packages
- 16
- Finished drugs by generic name
- 0
- Prescription products
- 0
- Over the counter products
- 0
- Started marketing in the last 12 months
- 0
- Earliest marketing start
- May 27, 2022
- openFDA record search
- api.fda.gov
Products by marketing category
Share of the company's products in commercial distribution.
| Marketing category | Products | Share |
|---|---|---|
| Drugs for further processing | 15 | 100% |
Products by type
| Type | Products | Share |
|---|---|---|
| Drugs for further processing | 15 | 100% |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Solution | 8 | 53.3% |
| Lozenge | 2 | 13.3% |
| Tablet, film coated | 2 | 13.3% |
| Tablet | 1 | 6.7% |
| Suppository | 1 | 6.7% |
| Capsule | 1 | 6.7% |
Newest products
By marketing start date.
| Product | Product NDC | Dosage form | Marketing category | Marketing start |
|---|---|---|---|---|
| Budesonide | 50941-599 | Capsule | Drugs for further processing | September 2, 2025 |
| Cocoa butter, phenylephrine hydrochloride | 50941-279 | Suppository | Drugs for further processing | March 28, 2025 |
| Acetaminophen, dextromethorphan hydrobromide, doxylamine succinate | 50941-850 | Solution | Drugs for further processing | March 26, 2024 |
| Doxylamine succinate | 50941-441 | Tablet | Drugs for further processing | December 22, 2023 |
| Acetaminophen, dextromethorphan hydrobromide, doxylamine succinate, phenylephrine hydrochloride | 50941-800 | Solution | Drugs for further processing | June 14, 2023 |
| Acetaminophen, dextromethorphan hydrobromide, guaifenesin, phenylephrine hydrochloride | 50941-511 | Solution | Drugs for further processing | June 12, 2023 |
| Acetaminophen, dextromethorphan hydrobromide, guaifenesin, phenylephrine | 50941-900 | Solution | Drugs for further processing | March 3, 2023 |
| Acetaminophen, ibuprofen | 50941-501 | Tablet, film coated | Drugs for further processing | February 24, 2023 |
| Ibuprofen | 50941-570 | Tablet, film coated | Drugs for further processing | January 20, 2023 |
| Acetaminophen, dextromethorphan hydrobromide, guaifenesin, phenylephrine hydrochloride | 50941-280 | Solution | Drugs for further processing | January 16, 2023 |
| Acetaminophen, dextromethorphan hydrobromide, doxylamine succinate | 50941-100 | Solution | Drugs for further processing | August 12, 2022 |
| Acetaminophen, dextromethorphan hydrobromide, doxylamine succinate, phenylephrine hydrochloride | 50941-059 | Solution | Drugs for further processing | August 12, 2022 |
| Nicotine polacrilex | 50941-957 | Lozenge | Drugs for further processing | July 1, 2022 |
| Nicotine polacrilex | 50941-734 | Lozenge | Drugs for further processing | July 1, 2022 |
| Aceteminophen, hydrobromide | 50941-010 | Solution | Drugs for further processing | May 27, 2022 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.